Group One Trading, L.P. Vaccinex, Inc. Transaction History

Group One Trading, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$0.34 - $0.48 $491 - $694	-1,446 Reduced 7.74%	17,225 $6,000
Q1 2023 May 12, 2023	SELL	$0.39 - $0.65 $897 - $1,495	-2,300 Reduced 10.97%	18,671 $7,000
Q3 2022 Nov 09, 2022	BUY	$0.48 - $109.22 $7,488 - $1.7 Million	15,600 Added 290.45%	20,971 $10,000
Q2 2022 Aug 11, 2022	BUY	$1.05 - $1.39 $500 - $663	477 Added 9.75%	5,371 $6,000
Q1 2022 May 12, 2022	BUY	$0.92 - $1.94 $3,408 - $7,187	3,705 Added 311.61%	4,894 $6,000
Q4 2021 Feb 11, 2022	BUY	$1.04 - $2.12 $1,236 - $2,520	1,189 New	1,189 $1,000
Q1 2021 May 12, 2021	SELL	$2.09 - $5.11 $209 - $511	-100 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$1.66 - $2.35 $166 - $235	100 New	100 $0

426K

Ticker VCNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,664,100
Market Cap $51.6M
Description
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab,...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.